Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor

被引:44
|
作者
Bosch, MP [1 ]
Campos, F
Niubó, I
Rosell, G
Díaz, JL
Brea, J
Loza, MI
Guerrero, A
机构
[1] CSIC, IIQAB, Dept Biol Organ Chem, ES-08034 Barcelona, Spain
[2] Univ Barcelona, Dept Pharmacol & Med Sci, CSIC, Fac Pharm, E-08028 Barcelona, Spain
[3] Lab Almirall Prodesfarma, Barcelona 08024, Spain
[4] Univ Santiago de Compostela, Fac Pharm, Dept Pharmacol, Santiago De Compostela 1578, Spain
关键词
D O I
10.1021/jm031143+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New adenosine derivatives have been synthesized and tested as putative agonists of adenosine receptors. Compounds 2-6 derive from the introduction of several types of substituents (electron donating, electron withdrawing, and halogens) in the para-position of the phenyl ring of the parent compound 1, and compound 7 lacks the hydroxyl group of amino alcohol 1. In radioligand binding assays using recombinant human A(1), A(2A), A(2B), and A(3) receptors, all compounds showed very low or negligible affinity for A(1) and A(2B) receptors but compounds 3, 5, and 7 displayed a remarkably potent affinity for the A2A receptor with K-i values of 1-5 nM. Bromo derivative 3 displayed a selectivity A(1)/A(2A) = 62 and A(3)/A(2A) = 16 whereas the presence of a hydroxyl group (compound 5) improved the selectivity of A(1)/A(2A) and A(3)/A(2A) to 120- and 28-fold, respectively. When the methoxy derivative 4 lacks the hydroxyl group on the side chain (compound 7), the binding affinity for A(2A) is increased to 1 nM, improving selectivity ratios to 356- and 100-fold against A(1) and A(3), respectively. In Chinese hamster ovary cells transfected with human A2A and A(2B) receptors, most compounds showed a remarkable activity for the A2A receptor, except chloro derivative 2, with EC50 values ranging from 1.4 to 8.8 nM. The compounds behaved as good A(2A) agonists, and all were more selective than 5'-(N-ethylearboxamino)adenosine (NECA), with A(2B)/A(2A) ratios of cAMP accumulation ranging from 48 for compound 2 to 666 for compound 7 while the corresponding A(2B)/A(2A) ratio for NECA was only 9. Compounds 1, 3, 5, and 7 also displayed higher selectivities than NECA up to 100-fold in isolated aortas of rat and guinea pig. In guinea pig tracheal rings precontracted by carbachol, compounds 2 and 4 were more potent than adenosine (100-fold) and NECA (10-fold), whereas compounds 1 and 7 displayed similar effects to NECA. Pretreatment of the tracheal rings with A(2), A(2A), and A(2B) receptor antagonists 3,7-dimethyl-L-propargylxanthine, 8-(3-chlorostyryl)caffeine, and alloxazine produced a marked inhibition of the tracheal relaxations induced by compounds 1, 2, and 4, but none of the compounds showed selectivity toward any of the adenosine receptors.
引用
收藏
页码:4041 / 4053
页数:13
相关论文
共 50 条
  • [1] Synthesis, biological activity and molecular docking analysis of new A2A adenosine receptor agonists
    Rodriguez, Anna M.
    Rosell, Gloria
    Bujons, Jordi
    Gutierrez-de-Teran, Hugo
    Rodriguez, David
    Brea, Jose M.
    Loza, M. Isabel
    Guerrero, Angel
    Pilar Bosch, M.
    PURINERGIC SIGNALLING, 2010, 6 : 41 - 42
  • [2] DEVELOPMENT OF NEW ADENOSINE A2A RECEPTOR AGONISTS: SYNTHESIS AND PHARMACOLOGICAL STUDIES
    Rodriguez, Anna M.
    Rosell, Gloria
    Brea, Jose M.
    Isabel Loza, M.
    Guerrero, Angel
    Pilar Bosch, M.
    DRUGS OF THE FUTURE, 2009, 34 : 170 - 170
  • [3] Adenosine A2A receptor agonists with potent antiplatelet activity
    Fuentes, Eduardo
    Fuentes, Manuel
    Caballero, Julio
    Palomo, Ivan
    Hinz, Sonja
    El-Tayeb, Ali
    Mueller, Christa E.
    PLATELETS, 2018, 29 (03) : 292 - 300
  • [4] The synthesis and biological activity of a highly selective adenosine A2a receptor agonist
    Borcherding, DR
    Lentz, NL
    Weintraub, PM
    Dudley, MW
    Secrest, R
    Kastner, PR
    Peet, NP
    NUCLEOSIDES & NUCLEOTIDES, 1999, 18 (10): : 2175 - 2191
  • [5] Synthesis and biological activity of trisubstituted adenines as A2A adenosine receptor antagonists
    Lambertucci, Catia
    Vittori, Sauro
    Mishra, Ram Chandra
    Dal Ben, Diego
    Klotz, Karl-Norbert
    Volpini, Rosaria
    Cristalli, Gloria
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2007, 26 (10-12): : 1443 - 1446
  • [6] New selective A2A agonists and A3 antagonists for human adenosine receptors: synthesis, biological activity and molecular docking studies
    Rodriguez, Anna
    Guerrero, Angel
    Gutierrez-de-Teran, Hugo
    Rodriguez, David
    Brea, Jose
    Loza, Maria I.
    Rosell, Gloria
    Bosch, M. Pilar
    MEDCHEMCOMM, 2015, 6 (06) : 1178 - 1185
  • [7] Design, synthesis, and evaluation of novel A2A adenosine receptor agonists
    Rieger, JM
    Brown, ML
    Sullivan, GW
    Linden, J
    Macdonald, TL
    JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (04) : 531 - 539
  • [8] Lessons From the Development of New Adenosine A2A Receptor Agonists
    Udelson, James E.
    JACC-CARDIOVASCULAR IMAGING, 2008, 1 (03) : 317 - 320
  • [9] Adenosine A2A Agonists: A Potential New Type of Atypical Antipsychotic
    Roberto Rimondini
    Sergi Ferré
    Sven Ove Ögren
    Kjell Fuxe
    Neuropsychopharmacology, 1997, 17 : 82 - 91
  • [10] A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update
    Guerrero, Angel
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (30) : 3597 - 3612